Sigyn Therapeutics, Inc. (SIGY)

OTCMKTS · Delayed Price · Currency is USD
0.0500
-0.0500 (-50.00%)
At close: Feb 27, 2026
-98.78%
Market Cap 81.17K
Revenue (ttm) n/a
Net Income (ttm) -3.22M
Shares Out 1.62M
EPS (ttm) -2.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 50,000
Average Volume 13,268
Open 0.0800
Previous Close 0.1000
Day's Range 0.0500 - 0.0800
52-Week Range 0.0450 - 5.0000
Beta -0.79
RSI 30.24
Earnings Date Feb 19, 2026

About Sigyn Therapeutics

Sigyn Therapeutics, Inc., a development-stage company, develops and sells medical devices to treat cancer and infectious disease disorders in the United States. Its lead product candidate is Sigyn therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community-acquired pneumonia, drug-resistant bacterial infections, and emerging pandemic threats. The company is also involved in the evaluation of Sig... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2019
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol SIGY
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.